Uncover key drivers, emerging technologies, and competitive movements shaping the arrayed clustered regularly interspaced short palindromic repeats (crispr) screening market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market?

The market size for arrayed clustered regularly interspaced short palindromic repeats (CRISPR) screening has expanded considerably over recent years. This market is forecasted to grow from $1.52 billion in 2025 to $1.79 billion in 2026, achieving a compound annual growth rate (CAGR) of 17.5%. The historical rise can be attributed to several factors including the expansion of functional genomics research, the availability of CRISPR editing reagents, the growth of academic screening programs, the early adoption of arrayed screening formats, and the increasing use of cell-based assays.

The arrayed clustered regularly interspaced short palindromic repeats (crispr) screening market size is anticipated to undergo rapid expansion in the coming years. It is projected to reach $3.43 billion by 2030, growing at a compound annual growth rate (CAGR) of 17.7%. This growth during the forecast period can be attributed to several factors, including the increasing demand for precision drug discovery, rising investments in gene therapy research, the broadening scope of disease modeling applications, the growing use of bioinformatics-driven screening, and enhanced collaboration between academia and industry. Key trends expected in the forecast period involve an increasing demand for targeted gene validation screens, the rising adoption of high-throughput arrayed crispr assays, the expanding integration of phenotypic data analytics, the proliferation of custom crispr screening services, and a heightened focus on the accuracy of functional genomics.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33018&type=smp

Which Drivers Are Supporting The Rise Of The Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market?

The growing emphasis on personalized medicine is projected to boost the expansion of the arrayed clustered regularly interspaced short palindromic repeats (CRISPR) screening market in the future. Personalized medicine involves a healthcare methodology where treatment and prevention plans are tailored to an individual’s distinct genetic makeup, biological traits, and lifestyle choices. Its uptake is expanding, driven by breakthroughs in genomics and molecular diagnostics, which enable therapies to be customized to an individual’s genetic profile for enhanced results. Arrayed CRISPR screening supports personalized medicine by methodically evaluating how particular gene modifications influence individual cellular reactions, thereby facilitating the discovery of patient-specific drug targets, forecasting treatment efficacy, and developing bespoke therapies based on an individual’s genetic and cellular blueprint. For example, in February 2024, as reported by the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 new personalized treatments for rare disease patients in 2023, an increase from six in 2022. Among the personalized treatments approved in 2023 were also seven cancer drugs and three for other diseases and conditions. Consequently, the heightened focus on personalized medicine is a key factor propelling the growth of the arrayed clustered regularly interspaced short palindromic repeats (CRISPR) screening market.

What Segments Are Identified Within The Structure Of The Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market?

The arrayed clustered regularly interspaced short palindromic repeats (crispr) screening market covered in this report is segmented –

1) By Product Type: Clustered Regularly Interspaced Short Palindromic Repeats Libraries; Reagents And Consumables; Instruments; Software And Services

2) By Application: Functional Genomics; Drug Discovery; Disease Modeling; Gene Validation; Other Applications

3) By End User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Contract Research Organizations; Other End Users

Subsegments:

1) By Clustered Regularly Interspaced Short Palindromic Repeats Libraries: Genome Wide Knockout Libraries; Targeted Gene Libraries; Activation Libraries; Repression Libraries; Custom Designed Libraries

2) By Reagents And Consumables: Guide Ribonucleic Acid Reagents; Cas Enzyme Reagents; Transfection Reagents; Cell Culture Reagents; Assay And Detection Reagents

3) By Instruments: Automated Liquid Handling Systems; High Throughput Screening Systems; Cell Imaging Systems; Flow Cytometry Instruments; Genomic Analysis Instruments

4) By Software And Services: Screening Design Software; Data Analysis Software; Bioinformatics Services; Screening Execution Services; Custom Assay Development Services

Which Competitive Trends Are Impacting The Structure Of The Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market?

Leading companies active in the arrayed clustered regularly interspaced short palindromic repeats (CRISPR) screening market are increasingly pursuing strategic partnerships to improve the precision of high-throughput phenotypic screening. A strategic partnership involves a formal collaboration where organizations pool resources, knowledge, or technologies to achieve mutual objectives, fostering quicker innovation, reducing risk, and broadening market reach without necessitating a merger or acquisition. For instance, in November 2023, AstraZeneca Plc, a UK-based science-led biopharmaceutical company, collaborated with the Medical Research Council (MRC), a UK-based government agency, and the Milner Therapeutics Institute (MTI) at the University of Cambridge, a UK-based biomedical research institute, to establish a Functional Genomics Screening Laboratory (FGSL). This cutting-edge facility is dedicated to advancing drug discovery, specifically aiming to map gene-phenotype relationships in chronic conditions such as cardiovascular and metabolic disorders, thereby bolstering UK genomics leadership through open academic collaborations. Its benefits include high-throughput automation for precise imaging and phenotyping in organoids or iPSCs, which surpasses pooled methods, along with advantages like free access for researchers, quicker target validation, and shared expertise to accelerate therapeutic developments.

Which Major Industry Participants Are Leading The Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Growth?

Major companies operating in the arrayed clustered regularly interspaced short palindromic repeats (crispr) screening market are Thermo Fisher Scientific Inc, Merck KGaA, GE HealthCare Technologies Inc, Applied Biological Materials Inc, Agilent Technologies Inc, Charles River Laboratories International Inc, Integrated DNA Technologies Inc, GenScript Biotech Corporation, Synthego Holdings LLC, Santa Cruz Biotechnology Inc, Creative Biolabs Inc, VectorBuilder Inc, Admera Health LLC, Addgene Inc, Ncardia, BioCat GmbH, Cellecta Inc, GeneCopoeia Inc, Creative Biogene Inc, and Aelian Biotechnology.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/arrayed-clustered-regularly-interspaced-short-palindromic-repeats-crispr-screening-market-report

Which Region Is Expected To Experience The Fastest Growth In The Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market?

North America was the largest region in the arrayed clustered regularly interspaced short palindromic repeats (CRISPR) screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the arrayed clustered regularly interspaced short palindromic repeats (crispr) screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=33018&type=smp

Browse Through More Reports Similar to the Global Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market 2026, By The Business Research Company

Crispr Technology Market 2026

https://www.thebusinessresearchcompany.com/report/crispr-technology-market

Crispr Gene Editing Market Report 2026

https://www.thebusinessresearchcompany.com/report/crispr-gene-editing-global-market-report

Crispr And Cas Gene Market Report 2026

https://www.thebusinessresearchcompany.com/report/crispr-and-cas-gene-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model